Auna (NYSE:AUNA – Get Free Report) and NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.
Institutional & Insider Ownership
16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 8.9% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a summary of current ratings for Auna and NeuroOne Medical Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Auna | 1 | 1 | 1 | 2 | 2.80 |
| NeuroOne Medical Technologies | 1 | 0 | 3 | 1 | 2.80 |
Risk and Volatility
Auna has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500.
Earnings & Valuation
This table compares Auna and NeuroOne Medical Technologies”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Auna | $1.17 billion | 0.32 | $29.39 million | $0.71 | 7.09 |
| NeuroOne Medical Technologies | $12.10 million | 3.38 | -$3.61 million | ($0.17) | -4.76 |
Auna has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Auna and NeuroOne Medical Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Auna | 4.40% | 13.52% | 3.27% |
| NeuroOne Medical Technologies | -78.34% | -119.92% | -78.86% |
Summary
Auna beats NeuroOne Medical Technologies on 9 of the 14 factors compared between the two stocks.
About Auna
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
